imfinzi
astrazeneca ab - durvalumab - karcinóma, nem kissejtes tüdő - daganatellenes szerek - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
beyfortus
astrazeneca ab - nirsevimab - immunrendszer sera, immunglobulinok, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
betaloc zok 100 mg retard tabletta
astrazeneca kft. - metoprolol -
naropin 20 mg/10 ml (2 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 75 mg/10 ml (7,5 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 200 mg/100 ml (2,0 mg/ml) infúzió
astrazeneca kft. - ropivacaine -
naropin 200 mg/20 ml (10 mg/ml) injekció
astrazeneca kft. - ropivacaine -
naropin 400 mg/200 ml (2,0 mg/ml) infúzió
astrazeneca kft. - ropivacaine -
betaloc zok 200 mg retard tabletta
astrazeneca kft. - metoprolol -
atacand plus 16 mg/12,5 mg tabletta
astrazeneca kft. - candesartan; hydrochlorothiazide -